BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1155 related articles for article (PubMed ID: 9793258)

  • 21. Hematopoietic stem cell transplantation in rheumatic diseases other than systemic sclerosis and systemic lupus erythematosus.
    Tyndall A
    J Rheumatol Suppl; 1997 May; 48():94-7. PubMed ID: 9150127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hematopoietic stem cell transplantation in autoimmune diseases].
    Albarracín F; López Meiller MJ; Naswetter G; Longoni H
    Medicina (B Aires); 2008; 68(2):153-63. PubMed ID: 18499968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stem cell transplantation for autoimmune disorders. Preclinical experiments.
    van Bekkum DW
    Best Pract Res Clin Haematol; 2004 Jun; 17(2):201-22. PubMed ID: 15302335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allogeneic bone marrow transplantation in models of experimental autoimmune encephalomyelitis: evidence for a graft-versus-autoimmunity effect.
    Van Wijmeersch B; Sprangers B; Rutgeerts O; Lenaerts C; Landuyt W; Waer M; Billiau AD; Dubois B
    Biol Blood Marrow Transplant; 2007 Jun; 13(6):627-37. PubMed ID: 17531772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of systemic and organ-specific autoimmune disease in mice by allogeneic bone marrow transplantation.
    Ikehara S; Nakamura T; Sekita K; Muso E; Yasumizu R; Ohtsuki H; Hamashima Y; Good RA
    Prog Clin Biol Res; 1987; 229():131-46. PubMed ID: 3299389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: a report from the EBMT and ABMTR.
    Snowden JA; Passweg J; Moore JJ; Milliken S; Cannell P; Van Laar J; Verburg R; Szer J; Taylor K; Joske D; Rule S; Bingham SJ; Emery P; Burt RK; Lowenthal RM; Durez P; McKendry RJ; Pavletic SZ; Espigado I; Jantunen E; Kashyap A; Rabusin M; Brooks P; Bredeson C; Tyndall A
    J Rheumatol; 2004 Mar; 31(3):482-8. PubMed ID: 14994391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hematopoietic stem cell transplantation in multiple sclerosis: experimental evidence to rethink the procedures.
    Karussis D; Slavin S
    J Neurol Sci; 2004 Aug; 223(1):59-64. PubMed ID: 15261562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progress toward production of immunologic tolerance with no or minimal toxic immunosuppression for prevention of immunodeficiency and autoimmune diseases.
    Good RA
    World J Surg; 2000 Jul; 24(7):797-810. PubMed ID: 10833246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Developments in hematopoietic stem-cell transplantation in the treatment of autoimmune diseases.
    Kozák T; Rychlík I
    Isr Med Assoc J; 2002 Apr; 4(4):268-71. PubMed ID: 12001701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hematopoietic stem cell transplantation procedures.
    Saccardi R; Gualandi F
    Autoimmunity; 2008 Dec; 41(8):570-6. PubMed ID: 18958744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hematopoietic stem cell transplantation (HSCT): an approach to autoimmunity.
    Alaez C; Loyola M; Murguía A; Flores H; Rodríguez A; Ovilla R; Ignacio G; Amador R; Salinas V; Perez F; Rodríguez D; Morales Z; Llinguin G; Vazquez A; Altamirano A; Gorodezky C
    Autoimmun Rev; 2006 Mar; 5(3):167-79. PubMed ID: 16483916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adult stem cells in the treatment of autoimmune diseases.
    van Laar JM; Tyndall A
    Rheumatology (Oxford); 2006 Oct; 45(10):1187-93. PubMed ID: 16777856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study.
    Fassas A; Passweg JR; Anagnostopoulos A; Kazis A; Kozak T; Havrdova E; Carreras E; Graus F; Kashyap A; Openshaw H; Schipperus M; Deconinck E; Mancardi G; Marmont A; Hansz J; Rabusin M; Zuazu Nagore FJ; Besalduch J; Dentamaro T; Fouillard L; Hertenstein B; La Nasa G; Musso M; Papineschi F; Rowe JM; Saccardi R; Steck A; Kappos L; Gratwohl A; Tyndall A; Samijn J;
    J Neurol; 2002 Aug; 249(8):1088-97. PubMed ID: 12195460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stem cells in the aetiopathogenesis and therapy of rheumatic disease.
    Moore J; Tyndall A; Brooks P
    Best Pract Res Clin Rheumatol; 2001 Dec; 15(5):711-26. PubMed ID: 11812017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The potential role of autologous stem cell transplantation in patients with systemic lupus erythematosus.
    Hahn BH
    J Rheumatol Suppl; 1997 May; 48():89-93. PubMed ID: 9150126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.
    Mengarelli A; Iori A; Guglielmi C; Romano A; Cerretti R; Torromeo C; Micozzi A; Fenu S; Laurenti L; Donato V; De Felice L; Arcese W
    Haematologica; 2002 Jan; 87(1):52-8. PubMed ID: 11801465
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allogeneic peripheral blood stem cell transplantation using a fludarabine-based low intensity conditioning regimen for malignant lymphoma.
    Nagler A; Slavin S; Varadi G; Naparstek E; Samuel S; Or R
    Bone Marrow Transplant; 2000 May; 25(10):1021-8. PubMed ID: 10828860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced-intensity transplantation with in vivo T-cell depletion and adjuvant dose-escalating donor lymphocyte infusions for chemotherapy-sensitive myeloma: limited efficacy of graft-versus-tumor activity.
    Peggs KS; Mackinnon S; Williams CD; D'Sa S; Thuraisundaram D; Kyriakou C; Morris EC; Hale G; Waldmann H; Linch DC; Goldstone AH; Yong K
    Biol Blood Marrow Transplant; 2003 Apr; 9(4):257-65. PubMed ID: 12720218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonmyeloablative stem cell transplantation and cell therapy for malignant and non-malignant diseases.
    Resnick IB; Shapira MY; Slavin S
    Transpl Immunol; 2005 Aug; 14(3-4):207-19. PubMed ID: 15982565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hematopoietic mixed chimerism derived from allogeneic embryonic stem cells prevents autoimmune diabetes mellitus in NOD mice.
    Verda L; Kim DA; Ikehara S; Statkute L; Bronesky D; Petrenko Y; Oyama Y; He X; Link C; Vahanian NN; Burt RK
    Stem Cells; 2008 Feb; 26(2):381-6. PubMed ID: 17975228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 58.